Inspire Medical Systems

company

About

Inspire Medical Systems develops implantable therapeutic devices for the treatment of obstructive sleep apnea.

  • 101 - 250

Details

Last Funding Type
Series B
Last Funding Money Raised
$17M
Industries
Biotechnology,Health Care,Medical Device,Therapeutics
Founded date
Jan 1, 2007
Number Of Employee
101 - 250
Operating Status
Active

Inspire Medical Systems is a developer of innovative, implantable neurostimulation technologies to treat Obstructive Sleep Apnea (OSA). Utilizing well-established technologies from the fields of cardiac pacing and neurostimulation, Inspire has developed a proprietary Upper Airway Stimulation (UAS) therapy for patients who suffer from OSA.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$109.50M
Inspire Medical Systems has raised a total of $109.50M in funding over 2 rounds. Their latest funding was raised on Nov 18, 2016 from a Series F round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 18, 2016 Series F $38M 1 Detail
May 15, 2014 Series E $40M 2 Detail
May 11, 2012 Series C $14.50M 2 Medtronic Detail
Jun 29, 2009 Series B $17M 1 Detail

Investments

Number of Investments
Number of Lead Investments
1
1
Inspire Medical Systems has made 1 investments. Their most recent investment was on Apr 27, 2022, when EnsoData raised $20M.
Date Company Name
Round Money Raised Industry Lead Investor
Apr 27, 2022 EnsoData
Series A $20M Analytics Yes

Investors

Number of Lead Investors
Number of Investors
1
2
Inspire Medical Systems is funded by 2 investors. Medtronic and GDN Holdings are the most recent investors.
Investor Name Lead Investor Funding Round
Medtronic Series F
GDN Holdings Series E